Health-related quality of life and productivity impact in haemophilia patients with inhibitors

Haemophilia

Volumn 15, Issue 4, 2009, Pages 911-917

  Brown, T Michelle ^a   Lee, W C ^b   Joshi, A V ^c   Pashos, C L ^a  

^a Abt Bio Pharma Solutions Inc   (United States)

^b Abt Bio Pharma Solutions Inc   (United States)

^c NOVO NORDISK INC   (United States)

Author keywords

Haemophilia; Inhibitors; Productivity; Quality of life

Indexed keywords

BLOOD CLOTTING FACTOR 8 INHIBITOR;

ABSENTEEISM; ADULT; AGE; ARTICLE; BLEEDING; CHILD; CONTROLLED STUDY; DAILY LIFE ACTIVITY; FEMALE; HEMOPHILIA; HEMOPHILIA A; HUMAN; IMMUNOLOGICAL TOLERANCE; MAJOR CLINICAL STUDY; MALE; MENTAL HEALTH; PAIN ASSESSMENT; PHYSICAL CAPACITY; PHYSICAL DISEASE; PRIORITY JOURNAL; PRODUCTIVITY; PROPHYLAXIS; QUALITY OF LIFE; SHORT FORM 12; TREATMENT OUTCOME; UNITED STATES;

ABSENTEEISM; ACTIVITIES OF DAILY LIVING; ADULT; BLOOD COAGULATION FACTOR INHIBITORS; FACTOR VIII; FEMALE; HEMOPHILIA A; HUMANS; MALE; NEEDS ASSESSMENT; QUALITY OF LIFE; QUESTIONNAIRES; TREATMENT OUTCOME; YOUNG ADULT;

EID: 67649884757     PISSN: 13518216     EISSN: 13652516     Source Type: Journal    
DOI: 10.1111/j.1365-2516.2009.02032.x     Document Type: Article

References (21)

1. Barr RD, Saleh M, Furlong W, Saleh M, Pai M, Walker I. Health status and health-related quality of life associated with haemophilia. Am J Hematol 2002; 71: 152-60.
2. Miners AH, Sabin CA, Tolley KH, Jenkinson C, Kind P, Lee CA. Assessing health-related quality-of-life in individuals with haemophilia. Haemophilia 1999; 5: 378-85.
3. Solovieva S. Clinical severity of disease, functional disability and health-related quality of life. Three-year follow-up study of 150 Finnish patients with coagulation disorders. Haemophilia 2001; 7: 53-63.
4. Aznar JA, Magallón M, Querol F, Gorina E, Tusell JM. The orthopaedic status of severe haemophiliacs in Spain. Haemophilia 2000; 6: 170-6.
5. Wang T, Zhang L, Li H, Zhao H, Yang R. Assessing health-related quality-of-life in individuals with haemophilia in China. Haemophilia 2004; 10: 370-5.
6. Molho P, Rolland N, Lebrun T et al. Epidemiological survey of the orthopaedic status of severe haemophilia A and B patients in France. Haemophilia 2000; 6: 23-32.
7. Shapiro AD, Donfield SM, Lynn HS et al. Defining the impact of haemophilia: The academic achievement in children with haemophilia study. Pediatrics 2001; 108: E105.
8. Leisner RJ, Khair K, Hann IM. The impact of prophylactic treatment on children with severe haemophilia. Br J Haematol 1996; 92: 973-8.
9. Djulbegovic B, Goldsmith G, Vaughn D et.al. Comparison of quality of life between HIV-positive haemophilia patients and HIV-negative haemophilia patients. Haemophilia 1996; 2: 166-72.
10. Royal S, Schramm W, Berntorp E et.al. Quality-of-life differences between prophylactic and on-demand factor replacement therapy in European haemophilia patients. Haemophilia 2002; 8: 44-50.
11. Naraine VS, Risebrough NA, Oh P et.al. Health-related quality-of-life treatments for severe haemophilia: Utility measurements using the Standard Gamble technique. Haemophilia 2002; 8: 112-20.
12. Wight J, Paisley S. The epidemiology of inhibitors in haemophilia A: A systematic review. Haemophilia 2003; 9: 418-35.
13. Gringeri A, Mantovani LG, Scalone L, Mannucci PM. Cost of care and quality of life for patients with haemophilia complicated by inhibitors: the COCIS Study Group. Blood 2003; 102: 2358-63.
14. Scalone L, Mantovani LG, Mannucci PM, Gringeri A, The COCIS Study Investigators. Quality-of-life is associated to the orthopaedic status in haemophilic patients with inhibitors. Haemophilia 2006; 12: 154-62.
15. Woolf A, Rappaport L, Reardon P, Ciborowski J, D'Angelo E, Bessette J. School functioning and disease severity in boys with hemophilia. J Dev Behav Pediatr 1989; 10: 81-5.
16. Nilsson IM, Berntorp E, Lofqvist T, Pettersson H. Twenty-five years' experience of prophylactic treatment in severe haemophilia A and B. J Intern Med 1992; 232: 25-32.
17. Aledort LM, Haschmyer RH, Pettersson H. A longitudinal study of orthopaedic outcomes for severe factor-VII-deficit haemophiliacs. The Orthopeadic Outcomes Study Group. J Intern Med 1994; 236: 391-9.
18. Ware JE Jr, Kosinski M, Turner-Bowker DM, Gandek B. User's Manual for the SF-12v2 Health Survey With a Supplement Documenting SF-12 Health Survey. Lincoln, RI: QualityMetric Incorporated, 2002.
19. Ware JE Jr, Kosinski M, Keller SD. SF-36 Physical and Mental Health Summary Scales: A User's Manual. Boston, MA: The Health Institute, 1994.
20. Apolone G, Mosconi P. The Italian SF-36 Health Survey: Translation, validation and norming. J Clin Epidemiol 1998; 51: 1025-36.
21. Honda K, Nagao T, Kamiya T et.al. Prospective matched case control study concerning the treatment and quality of life of hemophiliacs with inhibitors. Rinsho Ketsueki 1998; 39: 416-21.